Medicaid Health Plan Pharmacy Benefit



Michigan Medicaid Health Plan Common Formulary Stakeholder Meeting

When:   Monday, October 9, 2017 from 9:30 a.m. to 12 noon

Where:  Lansing Community College West – Campus Auditorium
5708 Cornerstone Drive, Lansing, 48917

RSVP:  Attendees are asked to RSVP for this meeting.  If you plan to attend, please notify Donna Kreps, at no later than September 27, 2017.

The Michigan Department of Health and Human Services (MDHHS) invites the public to attend a stakeholder meeting on October 9 regarding the Michigan Medicaid Health Plan Common Formulary.

In order to streamline drug coverage policies for Medicaid and Healthy Michigan Plan beneficiaries and providers, MDHHS has developed a formulary that is common across all contracted health plans for the current Comprehensive Health Plan contract.  The intent is to reduce interruptions in a beneficiary’s drug therapy due to a change in health plan.

The Common Formulary also includes certain drug utilization management tools, such as prior authorization criteria and step therapies.  Health plans may be less restrictive, but not more restrictive, than the coverage parameters of the Common Formulary.

The purpose of the stakeholder meeting is to provide an in-person forum for the public to comment on the Common Formulary.  This annual in-person forum supplements the quarterly written public comment periods.  Please note that drug rebates, the Fee-for-Service formulary, and drugs that are covered under the Fee-for-Service benefit will not be reviewed at this meeting.  In addition, the stakeholder meeting is not intended to be a venue for pharmaceutical drug product-specific presentations.


This webpage is designed to provide easy access for members and providers looking for information on the drugs and supplies covered by Michigan Medicaid Health Plans.

All plans must at a minimum cover the drugs listed on the Medicaid Health Plan Common Formulary.

History of Formulary Changes

General Formulary Information

Prior Authorization (PA) Step Therapy

The Prior Authorization criteria for drugs indicated on the Medicaid Health Plan Common Formulary as requiring PA is below:

Drug PA Criteria

A standard prior authorization form, FIS 2288, was created by the Michigan Department of Insurance and Financial Services (DIFS) to simplify the process of requesting prior authorization for prescription drugs. This form or a prior authorization used by a health plan may be used.

The Step Therapy criteria for drugs indicated on the Medicaid Health Plan Common Formulary as requiring ST is below:

Step Therapy Criteria


Medicaid Common Formulary Workgroup Members

Scroll down for health plan specific information.



Plans may choose to include additional drugs that are not on the Medicaid Health Plan Common Formulary in their own drug formularies. In addition, plans may enforce drug utilization management policies such as quantity limits, age and gender edits, prior authorization criteria and step therapies that are less restrictive than the coverage parameters of the Medicaid Health Plan Common Formulary. Click on the health plans below for more information about their formularies and pharmacy related contact information.


Aetna logo


Blue Cross Complete of Michigan Logo


HAP Midwest Health Plan Logo



Harbor Health Plan


McLaren Health Plan


Meridian Health Plan



Molina Healthcare


Priority Health


Total Health Care


UnitedHealthcare Community Plan


Upper Peninsula Health Plan





Current beneficiaries can find out which health plan they are enrolled in by calling the Beneficiairy Help Line at 800-642-3195 (TTY 866-501-5656) or by logging in to their myHealth Portal account online at


For more information on the drug benefit for people not enrolled in a health plan (Fee-for-Service Medicaid) visit

For more general information on Michigan Medicaid Health Plans, visit



October 24,2016 Stakeholder Meeting Presentation

Stakeholder Meeting Questions and Answers

Frequently Asked Questions for Drug Manufacturers   


The next Michigan Medicaid Health Plan Common Formulary public comment period will be announced here.